ArticleFrontiers in oncology2024

Octreotide plus IBI-318 plus anlotinib in the treatment of multiple neuroendocrine metastases of unknown primary lesions: a case report.

Haoyue Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.